Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | Aph-1 protein, putative | 0.0743 | 0.3779 | 1 |
Echinococcus multilocularis | gamma secretase subunit aph 1 | 0.1908 | 1 | 1 |
Loa Loa (eye worm) | gamma-secretase subunit aph-1 | 0.1908 | 1 | 1 |
Onchocerca volvulus | 0.0286 | 0.1336 | 1 | |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.0187 | 0.0187 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.1336 | 1 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0229 | 0.1033 | 0.6747 |
Schistosoma mansoni | subfamily A22A unassigned peptidase (A22 family) | 0.0229 | 0.1033 | 0.1033 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0071 | 0.0187 | 0.0187 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0578 | 0.0578 |
Brugia malayi | hypothetical protein | 0.008 | 0.0237 | 0.0237 |
Toxoplasma gondii | hypothetical protein | 0.0065 | 0.0153 | 0.6488 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0 | 0.5 |
Entamoeba histolytica | presenilin 1 peptidase, putative | 0.0229 | 0.1033 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0112 | 0.0405 | 0.0405 |
Trypanosoma brucei | Aph-1 protein, putative | 0.0743 | 0.3779 | 1 |
Brugia malayi | hypothetical protein | 0.008 | 0.0237 | 0.0237 |
Trypanosoma brucei | presenilin-like aspartic peptidase, putative | 0.0229 | 0.1033 | 0.2681 |
Echinococcus multilocularis | Nicastrin | 0.0112 | 0.0405 | 0.0405 |
Brugia malayi | Presenilin-like protein At2g29900 | 0.008 | 0.0237 | 0.0237 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0071 | 0.0187 | 0.0187 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.115 | 0.115 |
Echinococcus multilocularis | presenilin | 0.0229 | 0.1033 | 0.1033 |
Echinococcus granulosus | gamma secretase subunit aph 1 | 0.1908 | 1 | 1 |
Brugia malayi | Presenilin spe-4 | 0.008 | 0.0237 | 0.0237 |
Echinococcus multilocularis | Nicastrin | 0.0112 | 0.0405 | 0.0405 |
Echinococcus multilocularis | nicalin | 0.0041 | 0.0027 | 0.0027 |
Trypanosoma brucei | Presenilin enhancer-2 subunit of gamma secretase, putative | 0.0065 | 0.0153 | 0.0337 |
Brugia malayi | Presenilin spe-4 | 0.008 | 0.0237 | 0.0237 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.0229 | 0.1033 | 0.2681 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.0229 | 0.1033 | 0.2681 |
Echinococcus granulosus | presenilin enhancer 2 | 0.0215 | 0.0958 | 0.0958 |
Brugia malayi | Presenilin spe-4 | 0.008 | 0.0237 | 0.0237 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.0187 | 0.0187 |
Echinococcus granulosus | Nicastrin | 0.0112 | 0.0405 | 0.0405 |
Echinococcus multilocularis | presenilin enhancer 2 | 0.0215 | 0.0958 | 0.0958 |
Schistosoma mansoni | gamma-secretase subunit aph-1 | 0.1908 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.008 | 0.0237 | 0.0237 |
Loa Loa (eye worm) | presenilin spe-4 | 0.008 | 0.0237 | 0.0237 |
Leishmania major | presenilin-like aspartic peptidase, putative,presenilin-like aspartic peptidase, clan AD, family A22A, putative | 0.0229 | 0.1033 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.0187 | 0.0187 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0578 | 0.0578 |
Toxoplasma gondii | hypothetical protein | 0.008 | 0.0237 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0578 | 0.0578 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.115 | 0.115 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0071 | 0.0187 | 0.0187 |
Echinococcus granulosus | presenilin | 0.0229 | 0.1033 | 0.1033 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.0743 | 0.3779 | 1 |
Loa Loa (eye worm) | gamma-secretase subunit pen-2 | 0.0215 | 0.0958 | 0.0958 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0071 | 0.0187 | 0.0187 |
Brugia malayi | Presenilin family protein | 0.0229 | 0.1033 | 0.1033 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.0405 | 0.0405 |
Schistosoma mansoni | jumonji domain containing protein | 0.0071 | 0.0187 | 0.0187 |
Brugia malayi | gamma-secretase subunit pen-2 | 0.0215 | 0.0958 | 0.0958 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0229 | 0.1033 | 0.6747 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.0229 | 0.1033 | 0.6747 |
Brugia malayi | hypothetical protein | 0.0112 | 0.0405 | 0.0405 |
Brugia malayi | hypothetical protein | 0.0112 | 0.0405 | 0.0405 |
Echinococcus granulosus | nicalin | 0.0041 | 0.0027 | 0.0027 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0071 | 0.0187 | 0.0187 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.0187 | 0.0187 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.5012 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 6.5733 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 16.5113 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.